{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:53:51Z","timestamp":1756076031913},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jash.2013.09.002","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T22:30:27Z","timestamp":1382394627000},"page":"103-116","source":"Crossref","is-referenced-by-count":21,"title":["Effects of antihypertensive treatment in Asian populations: A meta-analysis of prospective randomized controlled studies (CARdiovascular protectioN group in Asia: CARNA)"],"prefix":"10.1016","volume":"8","author":[{"given":"Yuichiro","family":"Yano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Hoshide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2013.09.002_bib1","unstructured":"World Health Organization Media centre. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/index.html. Accessed September 1, 2013."},{"key":"10.1016\/j.jash.2013.09.002_bib2","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.jash.2013.09.002_bib3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(08)60655-8","article-title":"Global burden of blood-pressure-related disease, 2001","volume":"371","author":"Lawes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.09.002_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/00004872-200304000-00013","article-title":"Blood pressure and cardiovascular disease in the Asia Pacific region","volume":"21","author":"Lawes","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.111.187252","article-title":"Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region","volume":"59","author":"Arima","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.09.002_bib6","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.108.790048","article-title":"Cardiovascular disease and risk factors in Asia: a selected review","volume":"118","author":"Ueshima","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.09.002_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCULATIONAHA.111.018820","article-title":"Global variation in the relative burden of stroke and ischemic heart disease","volume":"124","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.09.002_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.jhh.1001054","article-title":"Epidemiology of hypertension in China and Japan","volume":"14","author":"Ueshima","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","article-title":"Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group","volume":"297","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.jash.2013.09.002_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.jhh.1001605","article-title":"Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study","volume":"17","author":"Zhou","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib11","first-page":"317","article-title":"Blood pressure levels, related factors, and hypertension control status of Japanese and Americans","volume":"5","author":"Baba","year":"1991","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib12","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/00004872-199610000-00013","article-title":"Shanghai trial of nifedipine in the elderly (STONE)","volume":"14","author":"Gong","year":"1996","journal-title":"J Hypertens"},{"issue":"12 Pt 1","key":"10.1016\/j.jash.2013.09.002_bib13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","article-title":"Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group","volume":"16","author":"Liu","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archinte.160.2.211","article-title":"Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group","volume":"160","author":"Wang","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jash.2013.09.002_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.HYP.34.5.1129","article-title":"Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group","volume":"34","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.09.002_bib16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2337\/diacare.27.4.874","article-title":"Asian RENAAL Study Investigators. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study","volume":"27","author":"Chan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2013.09.002_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1291\/hypres.27.181","article-title":"Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial","volume":"27","author":"Yui","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2013.09.002_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1291\/hypres.28.307","article-title":"Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients","volume":"28","author":"Suzuki","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2013.09.002_bib19","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/01.hjh.0000194120.42722.ac","article-title":"The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients","volume":"23","author":"Liu","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","article-title":"Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial","volume":"51","author":"Ogihara","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.09.002_bib21","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","article-title":"Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)","volume":"31","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2013.09.002_bib22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurheartj\/ehp101","volume":"30","author":"Kasanuki","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jash.2013.09.002_bib23","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2013.09.002_bib24","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result","volume":"108","year":"1995","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jash.2013.09.002_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","article-title":"Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension study","volume":"56","author":"Ogihara","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.09.002_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/hr.2010.186","article-title":"Effects of valsartan and amlodipine on cardiorenal protection in Japanese hypertensive patients: the Valsartan Amlodipine Randomized Trial","volume":"34","author":"Narumi","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2013.09.002_bib27","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/HJH.0b013e328348345d","article-title":"Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertension: a randomized controlled trial","volume":"29","author":"Matsuzaki","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib28","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s00125-011-2325-z","article-title":"Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study","volume":"54","author":"Imai","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.jash.2013.09.002_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/HYPERTENSIONAHA.111.184226","article-title":"Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study","volume":"59","author":"Muramatsu","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jash.2013.09.002_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.amjmed.2011.12.010","article-title":"Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients","volume":"125","author":"Ogawa","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jash.2013.09.002_bib31","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ndt\/gfs590","article-title":"Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial","volume":"28","author":"Iseki","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jash.2013.09.002_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.09.002_bib33","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.09.002_bib34","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2013.09.002_bib35","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jash.2013.09.002_bib36","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jash.2013.09.002_bib37","first-page":"1462","article-title":"2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"28","author":"Mancia","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jash.2013.09.002_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/hr.2009.34","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)","volume":"32","author":"Ogihara","year":"2009","journal-title":"Hypertens Res"},{"issue":"Suppl 1","key":"10.1016\/j.jash.2013.09.002_bib39","first-page":"S11","article-title":"Standards of medical care in diabetes\u20132013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jash.2013.09.002_bib40","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.09.002_bib41","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jash.2013.09.002_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11906-012-0314-3","article-title":"Blood pressure j-curve: current concepts","volume":"14","author":"Banach","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jash.2013.09.002_bib43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.STR.0000116869.64771.5A","article-title":"Blood pressure and stroke: an overview of published reviews","volume":"35","author":"Lawes","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jash.2013.09.002_bib44","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.09.002_bib45","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jash.2013.09.002_bib46","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials","volume":"336","author":"Turnbull","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jash.2013.09.002_bib47","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction: a meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jash.2013.09.002_bib48","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00004872-200306000-00002","article-title":"Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003","volume":"21","author":"Staessen","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jash.2013.09.002_bib49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.jhh.1001057","article-title":"Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention.","volume":"14","author":"Singh","year":"2000","journal-title":"J Hum Hypertens."},{"key":"10.1016\/j.jash.2013.09.002_bib50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.101.10.1102","article-title":"Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction","volume":"101","author":"Pristipino","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.09.002_bib51","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/hr.2010.259","article-title":"Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association","volume":"34","author":"Wang","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2013.09.002_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1291\/hypres.29.143","article-title":"Current status of antihypertensive prescription and associated blood pressure control in Japan","volume":"29","author":"Mori","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jash.2013.09.002_bib53","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1161\/hc4701.099488","article-title":"Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies","volume":"104","author":"Yusuf","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jash.2013.09.002_bib54","first-page":"26","article-title":"Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies","volume":"60","author":"Gupta","year":"2008","journal-title":"Indian Heart J"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317111300168X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193317111300168X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T23:54:14Z","timestamp":1539302054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193317111300168X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S193317111300168X"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2013.09.002","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}